Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CASSIOPEA-S-P-A-22762526/news/Cassiopea-Announces-First-Patient-to-be-Enrolled-in-Phase-II-Trial-for-the-Treatment-of-Androgenetic-29570404/?utm_source=whatsapp&utm_medium=social&utm_campaign=share